Everolimus and sunitinib as first-and second-line treatments of patients with metastatic papillary renal cell carcinoma (pRCC): A retrospective study of the GETUG (Groupe Francais d'Etude des Tumeurs Uro-Genitales).

Affiliation auteurs!!!! Error affiliation !!!!
TitreEverolimus and sunitinib as first-and second-line treatments of patients with metastatic papillary renal cell carcinoma (pRCC): A retrospective study of the GETUG (Groupe Francais d'Etude des Tumeurs Uro-Genitales).
Type de publicationJournal Article
Year of Publication2016
AuteursLinassier C, Albiges L, Chevreau C, Laguerre B, Oudard S, Gross-Goupil M, Gravis G, Goldwasser F, Rolland F, Delva R, Moise L, Tourani J-M, Vassal C, Zanetta S, Penel N, Flechon A, Theodore C, Barthelemy P, Saldana C, Escudier B
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedJAN 10
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2016.34.2_suppl.505